Eagle Pharmaceuticals: , Including Exhibit 99.1, Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended, Or Subject To The Liabilities Of That Section. The Information Shall Not Be Deemed Incorporated By Reference Into Any Other Filing With The Securities And Exchange Commission Made By The Company, Regardless Of Any General Incorporation Language In Such Filing, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Eagle Pharmaceuticals, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***